Dr. Clay Moss: On Metabolic Health, Insulin Resistance, Peptides, & Sleep Hygiene | TUH #267

Dr. Moss calls fasting insulin his favorite lab because it's a leading indicator. He sees patients with normal A1C and fasting insulin of 19, which he describes as 'the train wreck's coming.' Standard panels typically only include glucose and A1C, missing this window. He recommends pairing it with ApoB, homocysteine, hs-CRP, and a full hormonal panel to get a complete picture. The goal is to catch metabolic dysfunction early and reverse it with lifestyle changes before it becomes irreversible chronic disease.

This protocol was the cornerstone of the VA inpatient metabolic rehab program. Patients cut out all potentially reactive foods completely for 30 days. They kept a diet of whole foods, including grass-fed red meat. After 30 days, they reintroduced one food group at a time, taking surveys on mentation, pain, and overall feeling. If symptoms returned, that food was removed again. Dr. Moss says this process makes people acutely aware that what they eat directly affects how they feel. The program also included stress management (tai chi, meditation, yoga), exercise scaled to ability, and a post-program support group. Results were dramatic: triglycerides dropped from 140 to 55, LDL from 130 to 66, fasting glucose from 145 to 121, and homocysteine from 9.6 to 4.3 in 36 days without any new prescriptions.

Dr. Moss emphasizes that people often treat sleep in a vacuum, only focusing on the moment they lie down. He walks through the full day: getting natural sunlight early (cannot be replicated indoors), avoiding late meals (he aims for 2-3 hours before bed), cooling the bedroom to 66-69°F, using a warm shower or sauna to trigger cooling, eliminating all blue light by using red bulbs (his bedroom looks like a haunted house from the street), wearing a sleep mask when traveling, using a white noise machine for road noise, and taking magnesium glycinate. He also stresses the underrated importance of synchronizing sleep schedules with your partner to avoid disruptions, especially if one is a light sleeper.

Dr. Moss argues that for 40-50 years, health advice focused almost exclusively on cardio, neglecting strength. The mortality data is staggering: strength differences account for a 200-400% variance in death risk, far exceeding the impact of treating hypertension or diabetes pharmacologically. He points out that you can't supplement for being under-muscled; it's entirely in the patient's hands. He cites the Lift More study where older women lifting heavy (5-rep max) increased bone mineral density, overturning the old dogma that they should only do light weights to avoid fractures. He also ties muscle to metabolic health: as a glucose sink, it directly combats insulin resistance. This is why he insists that GLP-1 users must strength train to avoid sarcopenia.

Dr. Moss personally used BPC-157 and TB-500 during 75 Hard, a high-volume training challenge. He injected BPC-157 locally into a golfer's elbow and saw improvement within weeks. His Whoop data showed green recoveries despite two-a-day workouts. He also took sermorelin at night, 5 days on/2 off, under a clinician's guidance, and his labs improved. He emphasizes that peptides are the most exciting frontier in medicine but are currently forced into a black market because they're not taught in medical schools and are restricted by the FDA. He hopes for a future where peptides are prescribed and monitored in clinical settings, with proper education on mixing and dosing to avoid horror stories.

Dr. Moss laments that standard medical visits last 6-12 minutes and insurance doesn't cover key preventive labs like ApoB or fasting insulin. He recommends that young people get a comprehensive hormonal and metabolic panel when they are at their peak, so they have a personal baseline. Later, if symptoms like brain fog or fatigue appear, they can compare to their own historical numbers rather than population averages. He shares the example of testosterone: a man with 450 ng/dL at 18 and the same at 40 might be dismissed, but if his personal peak was 800, the drop is significant. He also advocates for cash-pay lab services, noting he paid $66 for five hormonal tests that insurance billed at $1,500.

Dr. Moss initially opposed GLP-1s but changed his view after seeing data on cardioprotection and possible cancer prevention. However, he stresses that they are a tool, not a miracle. The biggest danger is sarcopenia. He explains that if someone loses weight but also muscle, their metabolic health can actually worsen because muscle is the body's largest glucose disposal site. When they stop the drug, they regain fat but not muscle, ending up worse. He advocates for using GLP-1s only in a clinical setting with comprehensive support, including nutrition and exercise counseling, and hopes the FDA will allow compounding pharmacies to provide peptides safely so patients don't resort to unregulated online sources.

Dr. Moss describes an identity crisis in college that led him to weightlifting as a replacement for sports. He looked great but was constantly sick. Each time he went to urgent care, he got antibiotics and steroids, but no one asked about his sleep, caffeine, late meals, or training volume. This experience planted a deep distrust of the medical system and eventually drove him toward functional medicine. He now uses this story to illustrate that the mirror is a poor judge of internal health, and that many people can have chronic disease brewing while looking fit.

He argues that everything in modern life is becoming more comfortable, yet we are getting sicker. This isn't a coincidence. The basics — movement, stress management, community, whole food — seem too simple, so people dismiss them. He ties this to the metabolic health crisis, where insulin resistance from ultra-processed foods and sedentary living is the root of most chronic disease. The solution, he says, is to get back to our evolutionary roots, fixing things one by one.

The program takes one patient at a time for an intensive two-week (or longer) intervention. It includes teaching cooking, supplement education, full lab analysis, sleep hygiene, and stress management. After the program, patients join a support group of graduates, fostering community. Dr. Moss has tracked patients over time and seen weight loss, reduced depression scores, fewer medications, lower inflammation, and even arthritis improvement. The success is now raising questions in the government sector about whether this preventive model could avoid costly hospitalizations later. The protocol's core is a 30-day elimination diet removing gluten, soy, dairy, processed foods, artificial dyes, and alcohol, followed by systematic reintroduction to identify triggers. Stress management includes tai chi, meditation, or yoga based on patient preference. Exercise is scaled to ability, even if it's just walking to the first crack in the driveway.

Dr. Moss explains that GLP-1s can be life-saving for morbid obesity and type 2 diabetes, but the widespread, often unsupervised use is creating a new problem: people are losing fat but also significant muscle mass. Since muscle is the body's largest glucose sink and operates independently of insulin, losing it worsens metabolic health in the long run. When patients stop the drug, they have a worse fat-to-muscle ratio than before. He insists that GLP-1s must be paired with adequate protein intake, strength training, and physician guidance. He also notes that the current black-market peptide landscape is dangerous because people don't know how to mix or dose properly, leading to horror stories. He hopes the FDA will loosen restrictions so peptides can be prescribed and monitored safely.

He uses the example of testosterone: if a man had a level of 450 ng/dL at age 18 with no symptoms, and at 40 has the same 450 but now has brain fog and low libido, a doctor seeing only the current value might dismiss hormones as the cause. But trending would show that his personal normal was higher, and the drop is significant. Similarly, fasting insulin can be elevated years before A1C changes. He recommends getting comprehensive labs including hormones, ApoB, homocysteine, hs-CRP, and fasting insulin early, then repeating periodically to gamify health and catch deviations early.

He argues that the cash-pay model is often demonized as selfish, but for preventive care, spending money upfront on comprehensive labs and lifestyle interventions can save far more on the back end by avoiding chronic disease. The insurance model, with its algorithmic prior authorizations and short visit times, takes the art out of medicine and often denies necessary care. He hopes to practice outside the insurance system to spend more time with patients and focus on root causes.